arrow
J

Judit Kocsis

University of Debrecen
H指数:17
被引数:3,826

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Improvement in breast cancer survival across molecular subtypes in Hungary between 2011 and 2020: a nationwide, retrospective study
2025-03-310
OAAI
Early carcinoembryonic antigen (CEA) dynamics to predict the efficacy of fruquintinib (F) plus best supportive care (BSC) in patients with metastatic colorectal cancer (mCRC) enrolled in FRESCO-2
2024-03-220
PRE
Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011-2020
2023-09-186
OAAI
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

Fruquintinib与安慰剂在难治性转移性结直肠癌患者中的比较 (FRESCO-2): 一项国际,多中心,随机,双盲,3期研究

LANCET
IF88.5
2023-07-01101
PRE
FRESCO-2: A global phase III multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer
2022-09-0127
OAAI
Elacestrant, an oral selective estrogen receptor degrader (SERD), vs investigator's choice of endocrine monotherapy for ER+/HER2-advanced/metastatic breast cancer (mBC) following progression on prior endocrine and CDK4/6 inhibitor therapy: Results of EMERALD phase 3 trial
2022-02-157
PRE
Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy
2019-07-1915
OAAI